CO2点阵激光治疗汗管瘤的临床观察

Carbon dioxide fractional laser in treatment of syringoma： a clinical analysis

目的探讨CO2点阵激光治疗眼周汗管瘤的疗效和安全性。方法对28例汗管瘤患者进行CO2点阵激光治疗，并分别在治疗前、治疗结束后1个月和3个月进行数码照相、记录治疗结果和不良反应。通过治疗前后对比，观察临床效果和不良反应，医师和患者各自对治疗效果的满意度进行0～4级评分。结果28例治疗后1个月，74．99％的患者改善率超过50％；67．85％的患者达到满意或非常满意的效果。治疗后3个月，78．57％的患者改善率超过50％；71．42％的患者达到满意或非常满意的效果．与治疗后1个月对比差异无统计学意义（P〉0．05）。不良反应轻微。结论CO2点阵激光是汗管瘤安全、有效可行的治疗手段。

Objective To investigate the therapeutic efficacy and safety of carbon dioxide （CO2） fractional laser in treating periorbital syringoma. Methods Twenty-eight patients with syringoma were treated with ultrapulse CO2 fractional laser. Digital photos were taken before the treatment, 1 month and 3 months after the treatment to evaluate the efficacy. The recovery process and side effects were also recorded to assess the safety. Dermatologists rated the efficacy in 0-4 points scales. The patients assessed overall satisfaction in 0-4 point scales. Results One month after the treatment, 7,1.99 % of the patients had improvement rate of over 50 % and 67.85 % of the patients were satisfied or very satisfied with the overall efficacy. Three months after treatment, 78.57 % of the patients had improvement rate of over 50 % and 71.42 %of the patients were satisfied or very satisfied with the overall efficacy. There was no statistically significant difference between 1 month and 3 months （P〈0.05）. Conclusions Carbon dioxide fractional laser is an effective and safe approach to treat sy- ringoma with minimized side effects.